MERCK KGAA O.N./ DE0006599905 /
2024-04-19 8:47:09 PM | Chg. -0.650 | Volume | Bid8:52:58 PM | Ask8:52:58 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
146.050EUR | -0.44% | 534 Turnover: 77,723.700 |
145.250Bid Size: 137 | 146.100Ask Size: 137 | 18.84 bill.EUR | 1.51% | 22.47 |
GlobeNewswire
03-04
C4 Therapeutics Announces Strategic Discovery Research Collaboration with Merck KGaA, Darmstadt, Ger...
GlobeNewswire
2023-12-21
Arch Biopartners Receives Approval from Ethics Committee in Turkey to Proceed with Phase II Cardiac ...
GlobeNewswire
2023-12-14
ITM Executes License Agreement to Obtain Worldwide Exclusive License for the Clinical Development an...
GlobeNewswire
2023-10-17
ImmunOs Therapeutics Announces Clinical Trial Collaboration with Merck & Co., Inc., Rahway, NJ, USA